Alemany R - Search Results

1

Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer.

Koski A, Raki M, Nokisalmi P, Liikanen I, Kangasniemi L, Joensuu T, Kanerva A, Pesonen S, Alemany R, Hemminki A. Koski A, et al. Among authors: alemany r. Mol Ther. 2012 Jan;20(1):221-9. doi: 10.1038/mt.2011.230. Epub 2011 Nov 1. Mol Ther. 2012. PMID: 22044933 Free PMC article.

2

Complementary adenoviral vectors for oncolysis.

Alemany R, Lai S, Lou YC, Jan HY, Fang X, Zhang WW. Alemany R, et al. Cancer Gene Ther. 1999 Jan-Feb;6(1):21-5. doi: 10.1038/sj.cgt.7700001. Cancer Gene Ther. 1999. PMID: 10078960

3

A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency.

Suzuki K, Fueyo J, Krasnykh V, Reynolds PN, Curiel DT, Alemany R. Suzuki K, et al. Among authors: alemany r. Clin Cancer Res. 2001 Jan;7(1):120-6. Clin Cancer Res. 2001. PMID: 11205899

4

Characterization of the cyclooxygenase-2 promoter in an adenoviral vector and its application for the mitigation of toxicity in suicide gene therapy of gastrointestinal cancers.

Yamamoto M, Alemany R, Adachi Y, Grizzle WE, Curiel DT. Yamamoto M, et al. Among authors: alemany r. Mol Ther. 2001 Mar;3(3):385-94. doi: 10.1006/mthe.2001.0275. Mol Ther. 2001. PMID: 11273781 Free article.

5

[Oncolytic adenovirus for the treatment of cerebral tumors: past, present and future].

Alemany R, Gómez-Manzano C, Fueyo J. Alemany R, et al. Neurologia. 2001 Mar;16(3):122-7. Neurologia. 2001. PMID: 11333782 Review. Spanish.

6

Targeting oncolytic adenoviral agents to the epidermal growth factor pathway with a secretory fusion molecule.

Hemminki A, Dmitriev I, Liu B, Desmond RA, Alemany R, Curiel DT. Hemminki A, et al. Among authors: alemany r. Cancer Res. 2001 Sep 1;61(17):6377-81. Cancer Res. 2001. PMID: 11522629

7

CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors.

Alemany R, Curiel DT. Alemany R, et al. Gene Ther. 2001 Sep;8(17):1347-53. doi: 10.1038/sj.gt.3301515. Gene Ther. 2001. PMID: 11571572

8

Treatment of ovarian cancer with a tropism modified oncolytic adenovirus.

Bauerschmitz GJ, Lam JT, Kanerva A, Suzuki K, Nettelbeck DM, Dmitriev I, Krasnykh V, Mikheeva GV, Barnes MN, Alvarez RD, Dall P, Alemany R, Curiel DT, Hemminki A. Bauerschmitz GJ, et al. Among authors: alemany r. Cancer Res. 2002 Mar 1;62(5):1266-70. Cancer Res. 2002. PMID: 11888888

9

Oncolytic virotherapy of meningiomas in vitro with replication-competent adenovirus.

Grill J, Lamfers ML, van Beusechem VW, van der Valk P, Huisman A, Sminia P, Alemany R, Curiel DT, Vandertop WP, Gerritsen WR, Dirven CM. Grill J, et al. Among authors: alemany r. Neurosurgery. 2005;56(1):146-53; discussion 153-4. doi: 10.1227/01.neu.0000146207.55774.69. Neurosurgery. 2005. PMID: 15617597

10

Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancer.

Heideman DA, Steenbergen RD, van der Torre J, Scheffner M, Alemany R, Gerritsen WR, Meijer CJ, Snijders PJ, van Beusechem VW. Heideman DA, et al. Among authors: alemany r. Mol Ther. 2005 Dec;12(6):1083-90. doi: 10.1016/j.ymthe.2005.06.443. Epub 2005 Aug 8. Mol Ther. 2005. PMID: 16085463 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

205 results

Search Page

Filters